NCT00006669View on ClinicalTrials.gov

Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 1999

Primary Completion Date

January 31, 2000

Study Completion Date

January 31, 2000

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

BIOLOGICAL

sargramostim

DRUG

EPOCH regimen

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (2)

20010

Washington Cancer Institute, Washington D.C.

21237

Franklin Square Hospital Center, Baltimore

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER